Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-11
2005-10-11
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S269000, C514S275000, C544S322000, C544S323000, C544S324000, C544S325000, C544S326000, C544S327000, C544S328000, C544S329000
Reexamination Certificate
active
06953802
ABSTRACT:
Disclosed are compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.
REFERENCES:
patent: 5510332 (1996-04-01), Kogan et al.
patent: 330506 (1989-08-01), None
patent: WO 96/01644 (1996-11-01), None
Abraham, et al.,J. Clin. Invest., 93:776 (1994).
Bao, et al.,Diff., 52:239 (1993).
Baron, et al.,J. Clin. Invest., 93:1700 (1994).
Baron, et al.,J. Exp. Med., 177:57 (1993).
Burkly, et al.,Diabetes, 43:529 (1994).
Cybulsky, et al.,Science, 251:788 (1991).
Elices, et al.,Cell, 60:577-584 (1990).
Elices, et al.,J. Clin. Invest., 93:405 (1994).
Hamann, et al.,J. Immunology, 152:3238 (1994).
Kawaguchi, et al.,Japanese J. Cancer Res., 83:1304 (1992).
Lauri, et al.,British J. Cancer, 68:862 (1993.
Li, et al.,Arterioscler. Thromb., 13:197 (1993).
Mulligan, et al.,J. Immunology, 150:2407 (1993).
Okarhara, et al.,Can. Res., 54:3233 (1994).
Osborn,Cell, 6 2:3-6 (1990).
Paavonen, et al.,Int. J. Can., 58:298 (1994).
Paul, et al.,Transpl. Proceed., 25:813 (1993).
Postigo, et al.,J. Clin. Invest., 89:1445 (1991).
Pretolani, et al.,J. Exp. Med., 180:795 (1994).
Sasseville, et al.,Am. J. Path., 144:27 (1994).
Springer,Nature, 346:425-434 (1990).
van Dinther-Janssen, et al.,J. Immunology, 147:4207 (1991).
van Dinther-Janssen, et al.,Annals. Rheumatic Dis., 52:672 (1993).
Vedder, et al.,Surgery, 106:509 (1989).
Yang, et al.,Proc. Natl. Acad. Science(USA), 90:10494 (1993).
Yednock, et al.,Nature, 356:63 (1992).
Melik-Ogandzhanian, R. “Synthesis and antitumor activity of some N-2,5-dimethyloxazolo [5,4-d]pyrimidinyl-7-amino acids.”Chemical Abstracts104(34): 795, col. 1 (1986).
Ashwell Susan
Dressen Darren B.
Grant Francine S.
Konradi Andrei W.
Kreft Anthony
Elan Pharmaceuticals Inc.
Foley & Lardner LLP
Kifle Bruck
Wyeth
LandOfFree
Beta-amino acid derivatives-inhibitors of leukocyte adhesion... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Beta-amino acid derivatives-inhibitors of leukocyte adhesion..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta-amino acid derivatives-inhibitors of leukocyte adhesion... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3441284